Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings
Q2
DLA PIPER LLP (US) for CALIFORNIA APARTMENT ASSOCIATION
Q2
STANTON PARK GROUP for KYOWA KIRIN
Q2
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
2T
RICCHETTI INCORPORATED for IPSEN BIOPHARMACEUTICALS, INC.
Q2
DLA PIPER LLP (US) for XEROX HOLDINGS CORPORATION
Q2
LUPIN PHARMACEUTICALS INC for LUPIN PHARMACEUTICALS INC
Q2
BALLARD PARTNERS for PUBLIX SUPER MARKETS, INC.
Q2
MILLER STRATEGIES, LLC for RTW INVESTMENTS, LP
RR
JAMES P. KEESE for NATIONAL ORGANIZATION OF RARE DISORDERS, INC
Q2
MEHLMAN CONSULTING, INC. for WEDGEWOOD PHARMACY LLC
2T
STEPTOE LLP for AQUESTIVE THERAPEUTICS, INC.
Q2
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Q2
EMERGENT STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2T
ARENTFOX SCHIFF LLP for AMERICAN PHARMACY COOPERATIVE, INC.
Q2
RUBIN, TURNBULL & ASSOCIATES for CHARTWELL
Q2
RUBIN, TURNBULL & ASSOCIATES for PHRMA
Q2
RUBIN, TURNBULL & ASSOCIATES for USANTIBIOTICS
Q2
BGR GOVERNMENT AFFAIRS for CHARLES RIVER LABORATORIES
Q2
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
Q2
AKIN GUMP STRAUSS HAUER & FELD for CENTRIENT PHARMACEUTICALS LLC
Q2
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Q2
EMERGENT STRATEGIES for GENBIOPRO, INC.
Q2
AKIN GUMP STRAUSS HAUER & FELD for BRIGHTSPRING HEALTH SERVICES
Q2
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
Q2
MEHLMAN CONSULTING, INC. for THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA